Citation Impact
Citing Papers
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
2012 Standout
Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel In Vivo Pharmacodynamic Assays
2011
A First-in-Human Study of Conatumumab in Adult Patients with Advanced Solid Tumors
2010
Progress and challenges towards targeted delivery of cancer therapeutics
2018 Standout
Molecular Mechanisms of Apoptosis and Roles in Cancer Development and Treatment
2015
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
2011 Standout
The use of polymeric platinum(IV) prodrugs to deliver multinuclear platinum(II) drugs with reduced systemic toxicity and enhanced antitumor efficacy
2012
Combined modality therapy with TRAIL or agonistic death receptor antibodies
2011
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Clinical and pharmacological phase I study with accelerated titration design of a daily times five schedule of BBR3464, a novel cationic triplatinum complex
2000
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles
2013
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
2012
Polymer-drug conjugates: Recent development in clinical oncology
2008
Prodrug Strategies in Anticancer Chemotherapy
2007
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Playing the DISC: Turning on TRAIL death receptor-mediated apoptosis in cancer
2009
p16-Cdk4-Rb axis controls sensitivity to a cyclin-dependent kinase inhibitor PD0332991 in glioblastoma xenograft cells
2012
Phase II studies of BBR3464, a novel tri-nuclear platinum complex, in patients with gastric or gastro-oesophageal adenocarcinoma
2004
Nanocarriers for delivery of platinum anticancer drugs
2013
A phase I trial of ispinesib, a kinesin spindle protein inhibitor, with docetaxel in patients with advanced solid tumours
2008
Nano based drug delivery systems: recent developments and future prospects
2018 Standout
Antibody therapy of cancer
2012 Standout
Targeting cancer with small molecule kinase inhibitors
2008 Standout
Design considerations for tumour-targeted nanoparticles
2009 StandoutNobel
High-performance medicine: the convergence of human and artificial intelligence
2018 Standout
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
2015 Standout
Targeting apoptosis in cancer therapy
2020 Standout
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging
2009 Standout
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
2012 Standout
Strategies in the design of nanoparticles for therapeutic applications
2010 Standout
PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect
2010
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
2010 Standout
Microtubule-binding agents: a dynamic field of cancer therapeutics
2010 Standout
Application of Nanotechnology in Cancer Therapy and Imaging
2008
Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles
2010 Standout
Activation of apoptosis signalling pathways by reactive oxygen species
2016 Standout
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor-1 and receptor-2 agonists for cancer therapy
2009
Small-molecule delivery by nanoparticles for anticancer therapy
2010
TNF-related apoptosis-inducing ligand (TRAIL): A new path to anti-cancer therapies
2009
Emerging drugs for non-small-cell lung cancer
2007
Phase I and pharmacokinetic study of lexatumumab (HGS-ETR2) given every 2 weeks in patients with advanced solid tumors
2009
Directing cancer cells to self-destruct with pro-apoptotic receptor agonists
2008
Polymeric micelles in drug delivery: An insight of the techniques for their characterization and assessment in biorelevant conditions
2021 Standout
The TRAIL apoptotic pathway in cancer onset, progression and therapy
2008
Endocytosis of nanomedicines
2010 Standout
Phase II study of NK105, a paclitaxel-incorporating micellar nanoparticle, for previously treated advanced or recurrent gastric cancer
2011
PARP inhibition: PARP1 and beyond
2010
New Developments and Approaches in the Platinum Arena
2000
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Delivering nanomedicine to solid tumors
2010 Standout
DLS and zeta potential – What they are and what they are not?
2016 Standout
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Nanoscale Metal–Organic Frameworks for Biomedical Imaging and Drug Delivery
2011 Standout
Apoptosis: A Target for Anticancer Therapy
2018 Standout
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Nanoparticles in Photodynamic Therapy
2015 Standout
On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1
2012 Standout
Silver Nanoparticles: Synthesis, Characterization, Properties, Applications, and Therapeutic Approaches
2016 Standout
Copper induces cell death by targeting lipoylated TCA cycle proteins
2022 StandoutScience
Nanoparticle PEGylation for Imaging and Therapy
2011 Standout
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
2011 Standout
Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake
2011 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Light-Controlled Radical Polymerization: Mechanisms, Methods, and Applications
2016 Standout
Metal–Organic Frameworks in Biomedicine
2011 Standout
pH-Operated Nanopistons on the Surfaces of Mesoporous Silica Nanoparticles
2010 StandoutNobel
Analysis of nanoparticle delivery to tumours
2016 Standout
Oxime Ligation on the Surface of Mesoporous Silica Nanoparticles
2015 StandoutNobel
Ghost cytometry
2018 Science
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Nanotechnology and Cancer
2007
Principles and prospects for single-pixel imaging
2018 Standout
Clinical Translation of Nanomedicine
2015
Works of E. Ruth Plummer being referenced
A phase 1b study to assess the safety of lexatumumab, a human monoclonal antibody that activates TRAIL-R2, in combination with gemcitabine, pemetrexed, doxorubicin or FOLFIRI.
2007
A phase I study of a novel, trinuclear, platinum analogue, BBR3464, in patients with advanced solid tumors
1999
A phase I study of AT9283, an aurora kinase inhibitor, in patients with refractory solid tumors
2009
Phase I study of ispinesib in combination with carboplatin in patients with advanced solid tumors
2006
A phase Ib study to assess the safety of lexatumumab, a human monoclonal antibody that activates TRAIL-R2, in combination with gemcitabine, pemetrexed, doxorubicin or FOLFIRI
2007
High‐resolution imaging for the detection and characterisation of circulating tumour cells from patients with oesophageal, hepatocellular, thyroid and ovarian cancers
2015
A Phase I and Pharmacokinetic Study of Paclitaxel Poliglumex (XYOTAX), Investigating Both 3-Weekly and 2-Weekly Schedules
2005
Effective sensitization of temozolomide by ABT-888 is lost with development of temozolomide resistance in glioblastoma xenograft lines
2009